Recursion Pharmaceuticals Inc’s filing revealed that its Director Borgeson Blake unloaded Company’s shares for reported $76326.0 on Oct 15 ’24. In the deal valued at $6.67 per share,11,447 shares were sold. As a result of this transaction, Borgeson Blake now holds 7,089,007 shares worth roughly $47.92 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Burrell Terry-Ann bought 404,688 shares, generating $2,693,813 in total proceeds.
Before that, Borgeson Blake bought 11,447 shares. Recursion Pharmaceuticals Inc shares valued at $76,326 were divested by the Director at a price of $6.67 per share.
Morgan Stanley initiated its Recursion Pharmaceuticals Inc [RXRX] rating to an Equal-weight in a research note published on May 22, 2023; the price target was $8. A number of analysts have revised their coverage, including Needham’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. KeyBanc Capital Markets began covering RXRX with “an Overweight” recommendation on September 16, 2022. BofA Securities revised its rating on April 18, 2022. It rated RXRX as “a Neutral” which previously was an “a Buy”.
Price Performance Review of RXRX
On Monday, Recursion Pharmaceuticals Inc [NASDAQ:RXRX] saw its stock fall -2.59% to $6.76. Over the last five days, the stock has gained 0.60%. Recursion Pharmaceuticals Inc shares have fallen nearly -31.44% since the year began. Nevertheless, the stocks have risen 11.74% over the past one year. While a 52-week high of $15.74 was reached on 02/27/24, a 52-week low of $4.97 was recorded on 09/04/24. SMA at 50 days reached $6.70, while 200 days put it at $8.77.
Levels Of Support And Resistance For RXRX Stock
The 24-hour chart illustrates a support level at 6.59, which if violated will result in even more drops to 6.41. On the upside, there is a resistance level at 6.94. A further resistance level may holdings at 7.11. The Relative Strength Index (RSI) on the 14-day chart is 52.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 29.57%. Stochastics %K at 69.57% indicates the stock is a holding.
How much short interest is there in Recursion Pharmaceuticals Inc?
A steep rise in short interest was recorded in Recursion Pharmaceuticals Inc stocks on 2024-09-30, growing by 6.55 million shares to a total of 62.58 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 56.03 million shares. There was a rise of 10.46%, which implies that there is a positive sentiment for the stock.
